Quarterly report pursuant to Section 13 or 15(d)

Earnings per Share - Additional Information (Detail)

v3.22.1
Earnings per Share - Additional Information (Detail) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
2021 Equity Compensation Plan | Performance Stock Units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Share-based compensation arrangement by share-based payment award, additional shares issued 38,036  
Total fair value of vested shares $ 955,000  
2013 Equity Compensation Plan | Performance Stock Units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Share-based compensation arrangement by share-based payment award, additional shares issued   42,626
Total fair value of vested shares   $ 784,000
Share based compensation arrangement by share based payment award equity instruments other than options, grant date Mar. 23, 2022 Mar. 24, 2021
Stock options, expiration term from date of grant 3 years  
Share-based compensation arrangement by share based payment award, performance stock units outstanding 104,599 66,563
Share-based compensation arrangement by share based payment award, performance stock units aggregate grant fair value $ 2,000  
Stock option awards    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of diluted EPS (shares) 0 0